Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-17-011488
Filing Date
2017-05-02
Accepted
2017-05-02 17:46:55
Documents
2
Period of Report
2017-04-29

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6080
2 EX-24 DOCUMENT attachment1.htm EX-24 3824
  Complete submission text file 0000899243-17-011488.txt   11358
Mailing Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121 2062827100
CTI BIOPHARMA CORP (Issuer) CIK: 0000891293 (see all company filings)

EIN.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 501 ELLIOTT AVE. W. SUITE 400 SEATTLE WA 98119
Business Address
Telling Fred (Reporting) CIK: 0001382225 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-28386 | Film No.: 17806422